Results 161 to 170 of about 15,828 (290)

Acute thrombotic occlusion of the left main coronary artery in a hypercoagulable patient treated with intracoronary abciximab [PDF]

, 2001
Jay D. Schlaifer, William Horgan, Michael J. Malkowski   +2 more
openalex   +1 more source

Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects [PDF]

, 2001
Ute Klinkhardt, Jochen Graff, Dagmar Westrup, C.M. Kirchmaier, Hans‐Ulrich Esslinger, H.K. Breddin, Sebastian Harder   +6 more
openalex   +1 more source

Los inhibidores de los receptores plaquetarios IIb/IIIa en los síndromes coronarios agudos.

Revista Cubana de Cardiología y Cirugía Cardiovascular, 2012
Los inhibidores de los receptores IIb/IIIa, un nuevo grupo de antiagregantes plaquetarios, son potentes bloqueadores del receptor que media la agregación plaquetaria y de ese modo bloquean la vía final común de la formación del trombo plaquetario.
Fidel Manuel Cáceres Lóriga, Horacio Pérez López   +1 more
doaj  

Safety of Abciximab injection during endovascular treatment of ruptured aneurysms

Interventional Neuroradiology, 2015
J. Gentric, Joelle Brisson, A. Batista, J. Ghostine, J. Raymond, D. Roy, A. Weill   +6 more
semanticscholar   +1 more source

Costs and effects of combining stenting and abciximab (ReoPro®) in daily practice [PDF]

, 2001
J. E. F. Zwart-van Rijkom, Olaf H. Klungel, H.G.M. Leufkens, A.W. Broekmans, Stella Schrijver-van Velthoven, Victor A. Umans   +5 more
openalex   +1 more source

Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients. ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy.

Journal of the American College of Cardiology, 2012
D. Sibbing, I. Bernlochner, S. Schulz, Steffen Massberg, A. Schömig, Julinda Mehilli, A. Kastrati   +6 more
semanticscholar   +1 more source

Antiplatelet strategies: past, present, and future. [PDF]

J Thromb Haemost, 2023
Stanger L, Yamaguchi A, Holinstat M.
europepmc   +1 more source

Platelet CD62 expression and PDGF_AB secretion in patients undergoing PTCA and treatment with abciximab [PDF]

, 2001
Jochen Graff, Daniela Andries, Mathias Elsner, Dagmar Westrup, S. Bassus, Nicole Franz, Ute Klinkhardt, S. Harder   +7 more
openalex   +1 more source

Bleeding Complications of Anticoagulation Therapy Used in the Treatment of Acute Coronary Syndromes-Review of the Literature. [PDF]

J Clin Med
Kosowski M, Kocjan M, Mazurkiewicz M, Gamrot-Wrzoł M, Ryl S, Nowakowski K, Kawecki J, Kukulski T, Kawecki D, Morawiec-Migas B.   +9 more
europepmc   +1 more source

Emergent operation for percutaneous coronary rupture after abciximab administration [PDF]

, 2001
Charles S. Roberts, N.Ruben Bocanegra
openalex   +1 more source